Sunitinib does not impair natural killer cell function in patients with renal cell carcinoma
Jennifer Moeckel(Universitätsklinikum Erlangen), Evelyn Ullrich(Goethe University Frankfurt)
Cited by 2
Related Papers
High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
|Frontiers in Immunology|2020|110
Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma
|Frontiers in Immunology|2018|33